drugset / Trial / NCT00587132
Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
The purpose of this study is to test if secretin-enhanced CT is a useful noninvasive screening tool for pancreatic cancer in a high-risk population.
Timeline
- Start
- 2006-11
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Secretin | Other / unclassified | 0.2 ug/kg | Intravenous |